RetaMaps

Quality 1st Regenerative Health Solutions

Quality 1st Regenerative Health Solutions · 7104 Chicago Avenue · Richfield, MN 55423

4.8· 58 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • Medically supervised weight loss

About this practice

Quality 1st Regenerative Health Solutions is a medical and wellness clinic in Richfield, Minnesota, serving the Minneapolis-St. Paul area, with telehealth available. Its website lists medical weight loss, GLP-1 weight management, IV hydration, vitamin injections and body contouring, and says its weight-loss programs may include provider consultations, FDA-approved weight-loss medications when appropriate, and nutrition and lifestyle support, beginning with a consultation and lab work. Google shows a 4.8-star rating across 58 reviews dating back to 2022, with 2 in the past year, and reviewers most often mention the staff and the team's knowledge.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsYes
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 4.8
Google rating · 58 reviews
2
reviews in the past year (avg ★ 5.0)

Counts computed by RetaMaps from public Google reviews; most recent review 2026-05-26. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★4.8 across 58 Google reviews. Of the 55 reviews we analyzed, 53 (96%) are positive (4–5★) and 2 (4%) are negative (1–2★).

What patients like

  • Friendly, helpful staff8 reviews
  • Knowledgeable, professional providers8 reviews
  • Feeling listened to5 reviews
  • Short waits, on-time visits2 reviews

Common complaints

Very few complaints — only 2 negative reviews, with no recurring theme.

5★
52
4★
1
3★
0
2★
1
1★
1

Most recent Google reviews

Morgan P.★★★★★2026-05-26

Very clean kind and attentive

Brynn b.★★★★★2026-05-18

Had an amazing experience with Dr. Yvonne. I left feeling refreshed, energized, and genuinely cared for. The personalized approach really stood out. Definitely recommend to anyone in the Twin Cities looking to prioritize their health and wellness.

jacqueline j.★★★★★2025-09-24

I love this place. It’s a holistic clinic the owner and staff are very knowledgeable. I highly recommend it!

Lindsay S.★★★★★2025-04-16

Great experience. Very easy to make an appointment online. All my needs were met!

Kyle★★★★★2024-05-29

Very helpful got my appointment done and went above and beyond for me thank you

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Nearby providers in Richfield

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs